Skip to content

Needleless Connectors in Dialysis

A quality assurance project evaluating patient experience, staff experience and incidence of catheter related blood stream infections in two methods of needleless connections for haemodialysis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611001193965
Enrollment
15
Registered
2011-11-17
Start date
2012-03-07
Completion date
2014-12-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A quality assurance project to assess the two different methods of connecting blood lines to permcaths for haemodialysis.

Interventions

Patients who need temporary access for haemodialysis have a permcath inserted. When connecting the blood lines to the permcath for haemodialysis treatment 2 different methods can be used: 1. Open procedure: 2. Needleless connector procedure: This is a quality assurance project evaluating two methods of needleless connections for haemodialysis. Each procedure will be used for one month, then cross-over to the other method (A washout period is not possible as a patient needs constant treatment so

Patients who need temporary access for haemodialysis have a permcath inserted. When connecting the blood lines to the permcath for haemodialysis treatment 2 different methods can be used: 1. Open procedure: 2. Needleless connector procedure: This is a quality assurance project evaluating two methods of needleless connections for haemodialysis. Each procedure will be used for one month, then cross-over to the other method (A washout period is not possible as a patient needs constant treatment so connection by one or other method will always be required). 1. Open procedure: set up of a sterile field to connect the blood lines to the permcath. 2. Needleless procedure: use a a device called a BD Q-Syte to connect the blood lines to the permcath.

Sponsors

Eastern Health Integrated Renal Service
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient has a permcath in situ being used for haemodialysis (or other renal treatment such as plasmaphoresis)

Exclusion criteria

Inability to give informed consent. Patient has a current, active infection. Permcath not expected to be in situ for longer than 1 month.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026